- Čo priniesli klinické štúdie SPIRE-1 a SPIRE-2 s PCSK9 inhibítorom bo…
Number of the records: 1  

Čo priniesli klinické štúdie SPIRE-1 a SPIRE-2 s PCSK9 inhibítorom bokocizumabom pre klinickú prax?

  1. Čo priniesli klinické štúdie SPIRE-1 a SPIRE-2 s PCSK9 inhibítorom bokocizumabom pre klinickú prax? / Murín J. ... [et al.]. Cardiology letters Vol. 26, no. 2 (2017), s. 106-108
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all